4Griffith HB, Veerapen R.A direct transnasat approach to the sphenoid sinus [J] .J Neurosurg, 1987,66(1) :140-142.
5Black PM, Zervas NT, Candia GL. Incidence and management of complications of transsphenoidal operation for pituitary adenomas [J] .Neurosurgery, 1987,20(6) :920-924
6Jagannathan J, Yen C P, Pouratian N, et al. Stereotactic radiosurgery for pituitary, adenomas: a comprehensive review of indications, techniques and long - term results using the Gamma Knife [ J]. J Neurooncol,2009,92(3) :345 - 356.
7Essais D, Bouguerra R, Hamzaoui J, et al. Efficacy and safety of BRC in the treatment of macroprolactinemia[ J]. Ann Endoerinol, 2002,63:524 - 531.
8Corsello S M,Ubertini G,Ahomare M,et al. Giant prolactinomasinmen: efficacy of CAB treatment[J]. Clin Endocrinol ,2003 ,58 :662 - 670.
9Attanasio R,Barausse M,Cozzi R. GH/IGF - I normolization and tunor shrinkage during long - term treatment of acromegaly by lanreotide[J]. J Endocrinol Invest,2001,24:209 - 216.
10Ambrosio M R, Franceschetti P, Bondanelli M,et al. Efficacy and safety of the new 60 - mg formulation of the long - acting somatostatin analog lanreotide in the treatment of acromegaly[ J]. Metabolism,2002,51:387 - 393.
